Differential sensitivity of v-Myb and c-Myb to Wnt-1-induced protein degradation

Area of Science:

• Molecular Biology
• Oncology
• Signal Transduction

Background:

• The c-myb proto-oncogene product (c-Myb) is degraded via Wnt-1 signaling through TAK1, HIPK2, and NLK.
• This degradation involves direct binding of NLK and HIPK2 to c-Myb, leading to phosphorylation, ubiquitination, and proteasomal degradation.
• While c-Myb is a proto-oncogene, the related v-myb gene product exhibits transforming capacity.

Purpose of the Study:

• To investigate the molecular mechanisms underlying the differential resistance of v-Myb to Wnt-1-induced protein degradation compared to c-Myb.
• To identify specific structural and functional differences that contribute to the stability of v-Myb.

Main Methods:

• Comparative analysis of protein-protein interactions between v-Myb/c-Myb and HIPK2.
• Site-directed mutagenesis to alter hydrophobic amino acids in the v-Myb DNA-binding domain.
• Truncation of the C-terminal region of c-Myb to assess the role of NLK phosphorylation sites.
• Assessment of protein stability and degradation pathways.

Main Results:

• HIPK2 exhibits lower binding affinity to the DNA-binding domain of v-Myb than to c-Myb, a difference attributed to specific hydrophobic amino acid mutations.
• Truncation of the C-terminal region of c-Myb, which contains critical NLK phosphorylation sites, enhances protein stability.
• The C-terminal phosphorylation sites of c-Myb are more crucial for Wnt-1-induced degradation than other sites.

Conclusions:

• The reduced affinity of HIPK2 for v-Myb and the absence of critical C-terminal NLK phosphorylation sites in v-Myb contribute to its relative resistance to Wnt-1-induced degradation.
• This differential protein stability between v-Myb and c-Myb may partially account for the distinct transforming capacities of these proteins.